NCT01811186View on ClinicalTrials.gov

An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)

PHASE4CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions
Chronic Pain
Interventions
DRUG

Oxycodone/naloxone

Oxycodone/naloxone titration

Trial Locations (1)

Unknown

AMC, Seoul

All Listed Sponsors
lead

Mundipharma Korea Ltd

INDUSTRY

NCT01811186 - An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY) | Biotech Hunter | Biotech Hunter